Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 70 results.
User Information
Export Records
  1. 1.   Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins
  2. Tewary,Poonam; Brooks, Alan D.; Xu, Ya-Ming; Wijeratne, E. M. Kithsiri; Babyak, Ashley L.; Back, Timothy C.; Chari,Raj; Evans,Christine; Henrich,Curtis; Meyer,Thomas; Edmondson,Elijah; de Aquino, Maria T. Prudente; Kanagasabai, Thanigaivelan; Shanker, Anil; Gunatilaka, A. A. Leslie; Sayers, Thomas J.
  3. Cancer Research. 2021, Jun 15; 81(12): 3374-3386.
  1. 2.   Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-p-activated nitric oxide donor PABA/NO in malignant gliomas
  2. Kogias, E.; Osterberg, N.; Baumer, B.; Psarras, N.; Koentges, C.; Papazoglou, A.; Saavedra, J. E.; Keefer, L. K.; Weyerbrock, A.
  3. International Journal of Cancer. 2012, Mar; 130(5): 1184-1194.
  1. 3.   Antitumor Activity of a Novel Oncrasin Analogue Is Mediated by JNK Activation and STAT3 Inhibition
  2. Guo, W.; Wu, S. H.; Wang, L.; Wei, X. L.; Liu, X. Y.; Wang, J.; Lu, Z. M.; Hollingshead, M.; Fang, B. L.
  3. Plos One. 2011, Dec; 6(12):
  1. 4.   Activation of the c-Jun N-terminal Kinase/Activating Transcription Factor 3 (ATF3) Pathway Characterizes Effective Arylated Diazeniumdiolate-Based Nitric Oxide-Releasing Anticancer Prodrugs
  2. Maciag, A. E.; Nandurdikar, R. S.; Hong, S. Y.; Chakrapan, H.; Diwan, B.; Morris, N. L.; Shami, P. J.; Shiao, Y. H.; Anderson, L. M.; Keefer, L. K.; Saavedra, J. E.
  3. Journal of Medicinal Chemistry. 2011, Nov; 54(22): 7751-7758.
  1. 5.   Identification of Potential Protein Targets of Isothiocyanates by Proteomics
  2. Mi, L. X.; Hood, B. L.; Stewart, N. A.; Xiao, Z.; Govind, S.; Wang, X. T.; Conrads, T. P.; Veenstra, T. D.; Chung, F. L.
  3. Chemical Research in Toxicology. 2011, Oct; 24(10): 1735-1743.
  1. 6.   Targeting the extrinsic apoptosis signaling pathway for cancer therapy
  2. Sayers, T. J.
  3. Cancer Immunology Immunotherapy. 2011, Aug; 60(8): 1173-1180.
  1. 7.   Increased oxidative-modifications of cytosolic proteins in 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-exposed rat liver
  2. Upreti, V. V.; Moon, K. H.; Yu, L. R.; Lee, I. J.; Eddington, N. D.; Ye, X.; Veenstra, T. D.; Song, B. J.
  3. Proteomics. 2011, Jan; 11(2): 202-211.
  1. 8.   Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia
  2. Liu, X.; Ryl, L.; Yang, J.; Liao, A. J.; Aliaga, C.; Watts, R.; Tan, S. F.; Kaiser, J.; Shanmugavelandy, S. S.; Rogers, A.; Loughran, K.; Petersen, B.; Yuen, J.; Meng, F. X.; Baab, K. T.; Jarbadan, N. R.; Broeg, K.; Zhang, R. R.; Liao, J. S.; Sayers, T. J.; Kester, M.; Loughran, T. P.
  3. Blood. 2010, Nov; 116(20): 4192-4201.
  1. 9.   Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial
  2. Bobe, G.; Murphy, G.; Albert, P. S.; Sansbury, L. B.; Lanza, E.; Schatzkin, A.; Colburn, N. H.; Cross, A. J.
  3. British Journal of Cancer. 2010, Oct; 103(9): 1453-1461.
  1. 10.   Reduction of IKK alpha Expression Promotes Chronic Ultraviolet B Exposure-Induced Skin Inflammation and Carcinogenesis
  2. Xia, X. J.; Park, E.; Liu, B. G.; Willette-Brown, J.; Gong, W. H.; Wang, J. M.; Mitchell, D.; Fischer, S. M.; Hu, Y. L.
  3. American Journal of Pathology. 2010, May; 176(5): 2500-2508.
  1. 11.   Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant Bax
  2. Garg, H.; Salcedo, R.; Trinchieri, G.; Blumenthal, R.
  3. Cancer Gene Therapy. 2010, Mar; 17(3): 155-163.
  1. 12.   Activation of p73 and induction of Noxa by DNA damage requires NF-kappa B
  2. Martin, A. G.; Trama, J.; Crighton, D.; Ryan, K. M.; Fearnhead, H. O.
  3. Aging-Us. 2009, Mar; 1(3): 335-349.
  1. 13.   Ceramides: Branched alkyl chains in the sphingolipid siblings of diacylglycerol improve biological potency
  2. Kang, J. H.; Garg, H.; Sigano, D. M.; Francella, N.; Blumenthal, R.; Marquez, V. E.
  3. Bioorganic & Medicinal Chemistry. 2009 17(4): 1498-1505.
  1. 14.   Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells
  2. Sei, S.; Mussio, J. K.; Yang, Q. E.; Nagashima, K.; Parchment, R. E.; Coffey, M. C.; Shoemaker, R. H.; Tomaszewski, J. E.
  3. Molecular Cancer. 2009 8 AR 47
  1. 15.   Constitutive expression of human keratin 14 gene in mouse lung induces premalignant lesions and squamous differentiation
  2. Dakir, E.; Feigenbaum, L.; Linnoila, R. I.
  3. Carcinogenesis. 2008 29(12): 2377-2384.
  1. 16.   Conformationally constrained analogues of diacylglycerol. 29. Cells sort diacylglycerol-lactone chemical zip codes to produce diverse and selective biological activities
  2. Duan, D.; Sigano, D. M.; Kelley, J. A.; Lai, C. C.; Lewin, N. E.; Kedei, N.; Peach, M. L.; Lee, J.; Abeyweera, T. P.; Rotenberg, S. A.; Kim, H.; Kim, Y. H.; El Kazzouli, S.; Chung, J. U.; Young, H. A.; Young, M. R.; Baker, A.; Colburn, N. H.
  3. Journal of Medicinal Chemistry. 2008 51(17): 5198-5220.
  1. 17.   The metabolism of proline as microenvironmental stress substrate
  2. Phang, J. M.; Pandhare, J.; Liu, Y. M.
  3. Journal of Nutrition. 2008 138(10): 2008S-2015S.
  1. 18.   Suppressive oligodeoxynucleotides inhibit silica-induced pulmonary inflammation
  2. Sato, T.; Shimosato, T.; Alvord, W. G.; Klinman, D. M.
  3. Journal of Immunology. 2008 180(11): 7648-7654.
  1. 19.   Proteomic analysis identifies oxidative stress induction by adaphostin
  2. Stockwin, L. H.; Bumke, M. A.; Yu, S. X.; Webb, S. P.; Collins, J. R.; Hollingshead, M. G.; Newton, D. L.
  3. Clinical Cancer Research. 2007, Jun; 13(12): 3667-3681.
  1. 20.   Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13
  2. Ivanov, S. V.; Salnikow, K.; Ivanova, A. V.; Bai, L.; Lerman, M. I.
  3. Oncogene. 2007, Feb; 26(6): 802-812.
  1. 21.   Interferon: Cellular executioner or white knight?
  2. Maher, S. G.; Romero-Weaver, A. L.; Scarzello, A. J.; Gamero, A. M.
  3. Current Medicinal Chemistry. 2007 14(12): 1279-1289.
  1. 22.   Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis
  2. Timofeeva, O. A.; Plisov, S.; Evseev, A. A.; Peng, S.; Jose-Kampfner, M.; Lovvorn, H. N.; Dome, J. S.; Perantoni, A. O.
  3. Oncogene. 2006, Dec; 25(58): 7555-7564.
  1. 23.   Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer
  2. Jazii, F. R.; Najafi, Z.; Malekzadeh, R.; Conrads, T. P.; Ziaee, A. A.; Abnet, C.; Yazdznbod, M.; Karkhane, A. A.; Salekdeh, G. H.
  3. World Journal of Gastroenterology. 2006, Nov; 12(44): 7104-7112.
  1. 24.   Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2
  2. Yang, Y. A.; Zhang, G. M.; Feigenbaum, L.; Zhang, Y. E.
  3. Cancer Cell. 2006, Jun; 9(6): 445-457.
  1. 25.   Comparison of the human and worm p53 structures suggests a way for enhancing stability
  2. Pan, Y. P.; Ma, B. Y.; Levine, A. J.; Nussinov, R.
  3. Biochemistry. 2006, Mar; 45(12): 3925-3933.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel